Werutsky G, Reinert T, Rosa ML, Barrios CH, et al. Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors. Clin Breast Cancer 2021 Apr 20. pii: S1526-8209(21)00071.
PMID: 33992526